ANIK Annual Cash & Cash Equivalents
$72.87 M
-$13.46 M-15.59%
31 December 2023
Summary:
As of January 27, 2025, ANIK annual cash & cash equivalents is $72.87 million, with the most recent change of -$13.46 million (-15.59%) on December 31, 2023. During the last 3 years, it has fallen by -$22.95 million (-23.95%). ANIK annual cash & cash equivalents is now -53.72% below its all-time high of $157.46 million, reached on December 31, 2019.ANIK Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANIK Quarterly Cash And Cash Equivalents
$62.37 M
-$454.00 K-0.72%
30 September 2024
Summary:
As of January 27, 2025, ANIK quarterly cash and cash equivalents is $62.37 million, with the most recent change of -$454.00 thousand (-0.72%) on September 30, 2024. Over the past year, it has dropped by -$8.28 million (-11.72%). ANIK quarterly cash and cash equivalents is now -60.39% below its all-time high of $157.46 million, reached on December 31, 2019.ANIK Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANIK Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.6% | -11.7% |
| 3 y3 years | -23.9% | -31.4% |
| 5 y5 years | -18.2% | -39.7% |
ANIK Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -22.8% | at low | -33.9% | at low |
| 5 y | 5-year | -53.7% | at low | -60.4% | at low |
| alltime | all time | -53.7% | +2702.6% | -60.4% | +4354.9% |
Anika Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $62.37 M(-0.7%) |
| June 2024 | - | $62.82 M(-8.5%) |
| Mar 2024 | - | $68.63 M(-5.8%) |
| Dec 2023 | $72.87 M(-15.6%) | $72.87 M(+3.1%) |
| Sept 2023 | - | $70.65 M(+8.6%) |
| June 2023 | - | $65.07 M(-18.4%) |
| Mar 2023 | - | $79.74 M(-7.6%) |
| Dec 2022 | $86.33 M(-8.5%) | $86.33 M(-1.7%) |
| Sept 2022 | - | $87.78 M(-4.0%) |
| June 2022 | - | $91.39 M(+1.2%) |
| Mar 2022 | - | $90.33 M(-4.3%) |
| Dec 2021 | $94.39 M(-1.5%) | $94.39 M(+3.7%) |
| Sept 2021 | - | $90.98 M(-6.4%) |
| June 2021 | - | $97.18 M(+2.7%) |
| Mar 2021 | - | $94.60 M(-1.3%) |
| Dec 2020 | $95.82 M(-39.1%) | $95.82 M(-8.1%) |
| Sept 2020 | - | $104.22 M(-10.7%) |
| June 2020 | - | $116.75 M(+77.3%) |
| Mar 2020 | - | $65.83 M(-58.2%) |
| Dec 2019 | $157.46 M(+76.8%) | $157.46 M(+52.3%) |
| Sept 2019 | - | $103.38 M(+48.9%) |
| June 2019 | - | $69.41 M(-27.3%) |
| Mar 2019 | - | $95.51 M(+7.3%) |
| Dec 2018 | $89.04 M(-33.2%) | $89.04 M(+8.8%) |
| Sept 2018 | - | $81.83 M(-35.1%) |
| June 2018 | - | $126.05 M(-11.1%) |
| Mar 2018 | - | $141.80 M(+6.4%) |
| Dec 2017 | $133.26 M(+27.8%) | $133.26 M(+5.0%) |
| Sept 2017 | - | $126.96 M(+7.7%) |
| June 2017 | - | $117.87 M(-1.3%) |
| Mar 2017 | - | $119.37 M(+14.5%) |
| Dec 2016 | $104.26 M(-5.8%) | $104.26 M(+6.3%) |
| Sept 2016 | - | $98.05 M(+10.0%) |
| June 2016 | - | $89.13 M(-4.0%) |
| Mar 2016 | - | $92.84 M(-16.1%) |
| Dec 2015 | $110.71 M(+10.5%) | $110.71 M(+2.1%) |
| Sept 2015 | - | $108.47 M(+4.4%) |
| June 2015 | - | $103.92 M(+4.1%) |
| Mar 2015 | - | $99.80 M(-0.4%) |
| Dec 2014 | $100.16 M(+58.1%) | $100.16 M(+39.5%) |
| Sept 2014 | - | $71.77 M(-15.4%) |
| June 2014 | - | $84.88 M(+3.3%) |
| Mar 2014 | - | $82.16 M(+29.7%) |
| Dec 2013 | $63.33 M(+43.7%) | $63.33 M(-1.1%) |
| Sept 2013 | - | $64.06 M(+18.3%) |
| June 2013 | - | $54.14 M(+6.2%) |
| Mar 2013 | - | $50.97 M(+15.7%) |
| Dec 2012 | $44.07 M(+23.2%) | $44.07 M(+10.6%) |
| Sept 2012 | - | $39.86 M(+5.1%) |
| June 2012 | - | $37.91 M(+11.5%) |
| Mar 2012 | - | $34.00 M(-5.0%) |
| Dec 2011 | $35.78 M(+26.9%) | $35.78 M(+23.2%) |
| Sept 2011 | - | $29.05 M(+8.3%) |
| June 2011 | - | $26.83 M(-7.7%) |
| Mar 2011 | - | $29.08 M(+3.1%) |
| Dec 2010 | $28.20 M(+15.5%) | $28.20 M(+9.5%) |
| Sept 2010 | - | $25.77 M(+9.0%) |
| June 2010 | - | $23.65 M(+2.1%) |
| Mar 2010 | - | $23.17 M(-5.2%) |
| Dec 2009 | $24.43 M(-43.4%) | $24.43 M(-36.6%) |
| Sept 2009 | - | $38.54 M(-2.6%) |
| June 2009 | - | $39.55 M(-2.2%) |
| Mar 2009 | - | $40.43 M(-6.4%) |
| Dec 2008 | $43.19 M | $43.19 M(+22.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2008 | - | $35.37 M(-5.2%) |
| June 2008 | - | $37.30 M(-4.3%) |
| Mar 2008 | - | $38.95 M(+8.5%) |
| Dec 2007 | $35.90 M(-23.9%) | $35.90 M(-22.2%) |
| Sept 2007 | - | $46.16 M(+3.1%) |
| June 2007 | - | $44.75 M(+2.2%) |
| Mar 2007 | - | $43.78 M(-7.2%) |
| Dec 2006 | $47.17 M(+5.4%) | $47.17 M(-0.5%) |
| Sept 2006 | - | $47.42 M(+2.8%) |
| June 2006 | - | $46.13 M(+3.8%) |
| Mar 2006 | - | $44.46 M(-0.6%) |
| Dec 2005 | $44.75 M(+13.7%) | $44.75 M(-2.5%) |
| Sept 2005 | - | $45.87 M(+14.9%) |
| June 2005 | - | $39.93 M(-1.0%) |
| Mar 2005 | - | $40.34 M(+2.5%) |
| Dec 2004 | $39.34 M(+169.6%) | $39.34 M(+15.7%) |
| Sept 2004 | - | $34.00 M(+1.4%) |
| June 2004 | - | $33.54 M(-2.8%) |
| Mar 2004 | - | $34.50 M(+136.4%) |
| Dec 2003 | $14.59 M(+32.6%) | $14.59 M(+15.7%) |
| Sept 2003 | - | $12.61 M(+10.1%) |
| June 2003 | - | $11.45 M(+9.2%) |
| Mar 2003 | - | $10.49 M(-4.7%) |
| Dec 2002 | $11.00 M(+21.4%) | $11.00 M(+52.8%) |
| Sept 2002 | - | $7.20 M(-3.7%) |
| June 2002 | - | $7.48 M(-28.4%) |
| Mar 2002 | - | $10.45 M(+15.3%) |
| Dec 2001 | $9.06 M(+9.7%) | $9.06 M(-9.4%) |
| Sept 2001 | - | $10.00 M(+21.0%) |
| June 2001 | - | $8.26 M(+29.4%) |
| Mar 2001 | - | $6.39 M(-22.7%) |
| Dec 2000 | $8.27 M(+29.2%) | $8.27 M(+45.6%) |
| Sept 2000 | - | $5.68 M(+3.8%) |
| June 2000 | - | $5.47 M(-38.9%) |
| Mar 2000 | - | $8.95 M(+39.8%) |
| Dec 1999 | $6.40 M(-40.2%) | $6.40 M(+357.1%) |
| Sept 1999 | - | $1.40 M(-73.1%) |
| June 1999 | - | $5.20 M(-7.1%) |
| Mar 1999 | - | $5.60 M(-47.7%) |
| Dec 1998 | $10.70 M(-52.9%) | $10.70 M(-15.7%) |
| Sept 1998 | - | $12.70 M(-46.0%) |
| June 1998 | - | $23.50 M(+4.9%) |
| Mar 1998 | - | $22.40 M(-1.3%) |
| Dec 1997 | $22.70 M(+740.7%) | $22.70 M(+632.3%) |
| Sept 1997 | - | $3.10 M(+6.9%) |
| June 1997 | - | $2.90 M(+11.5%) |
| Mar 1997 | - | $2.60 M(-10.3%) |
| Dec 1996 | $2.70 M(-27.0%) | - |
| Nov 1996 | - | $2.90 M(-21.6%) |
| Aug 1996 | - | $3.70 M(-7.5%) |
| Aug 1996 | $3.70 M(+32.1%) | - |
| May 1996 | - | $4.00 M(+166.7%) |
| Feb 1996 | - | $1.50 M(-31.8%) |
| Nov 1995 | - | $2.20 M(-21.4%) |
| Aug 1995 | $2.80 M(+7.7%) | $2.80 M(-15.2%) |
| May 1995 | - | $3.30 M(+106.3%) |
| Feb 1995 | - | $1.60 M(-20.0%) |
| Nov 1994 | - | $2.00 M(-23.1%) |
| Aug 1994 | $2.60 M(-49.0%) | $2.60 M(-21.2%) |
| May 1994 | - | $3.30 M(-5.7%) |
| Feb 1994 | - | $3.50 M(-22.2%) |
| Nov 1993 | - | $4.50 M(-11.8%) |
| Aug 1993 | $5.10 M | $5.10 M(-5.6%) |
| May 1993 | - | $5.40 M |
FAQ
- What is Anika Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Anika Therapeutics?
- What is Anika Therapeutics annual cash & cash equivalents year-on-year change?
- What is Anika Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Anika Therapeutics?
- What is Anika Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Anika Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of ANIK is $72.87 M
What is the all time high annual cash & cash equivalents for Anika Therapeutics?
Anika Therapeutics all-time high annual cash & cash equivalents is $157.46 M
What is Anika Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, ANIK annual cash & cash equivalents has changed by -$13.46 M (-15.59%)
What is Anika Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ANIK is $62.37 M
What is the all time high quarterly cash and cash equivalents for Anika Therapeutics?
Anika Therapeutics all-time high quarterly cash and cash equivalents is $157.46 M
What is Anika Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, ANIK quarterly cash and cash equivalents has changed by -$8.28 M (-11.72%)